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Background: Students pursuing higher education are struggling with psychological
distress, which in turn may negatively affect their academic self-efficacy and study
progress. Although psychotropic drug use is widespread and increasing, patterns of
psychotropic drug use among students are not well-known.
Aim: To describe prevalence and gender differences in psychotropic drug use among
Norwegian students in higher education, and to examine associations with level of
psychological distress.
Methods: The study is based on data from the Norwegian Student’s Health
and Well-being Study (SHoT), 2018, a national survey including all fulltime students
aged 18–35 years in higher education. Our sample included 49,836 students, 69%
females. Use of psychotropic drugs and psychological distress (The Hopkins Symptoms
Checklist [HSCL-25]) were self-reported. Generalised linear models were used to assess
associations between psychological distress and psychotropic drug use.
Results: Psychotropic drug use wasmore frequent among female thanmale students: 4
vs. 2% daily antidepressants usage; 5 vs. 3% last month use of anxiolytics/tranquillisers;
and 8 vs. 5% last month use of hypnotics. In contrast, male students reported use of
performance enhancing drugs more often than females (7 vs. 5%). Adjusted associations
between high level of psychological distress (HSCL-25 ≥ 2.0) and use of psychotropics,
showed an about 2-fold increased relative risk, largely consequent across drug classes
and genders.
Conclusion: Prevalence and gender patterns of intake of the most common
psychotropic drug classes among Norwegian students are comparable to previous
studies. Unexpectedly, among students with moderate to severe psychological distress,
the patterns of psychotropic drug use were more or less identical between genders.
Keywords: students, mental health, psychological distress, psychotropics, antidepressants, hypnotics,
anxiolytics, gender differences
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INTRODUCTION
Psychological distress is highly prevalent among university and
college students worldwide (1) and often has negative effects on
several domains of students’ life (2, 3). Psychological distress
is defined as emotional suffering characterised by symptoms
like depression (e.g., loss of interest, sadness, hopelessness),
anxiety (e.g., restlessness, feeling tense) and functional or somatic
symptoms (e.g., headache, insomnia, poor appetite, sexual
dysfunction, and lack of energy) (4). A recent literature review
found that psychological distress was more prevalent and severe
among university students compared to their non-studying age-
matched peers in the general population (5). Furthermore,
psychological distress among students is strongly associated with
lower academic self-efficacy and reduced study progress (6), and
increased risk of suicidal thoughts and behaviours (7). Thus,
preventive interventions, early detection, and optimal treatment
of mental illness among students, as well as general improvement
of students’ mental health, have become urgent matters.
Both non-pharmacological interventions and psychotropic
drugs are cornerstones in the treatment of mental illnesses,
and women are more frequent users of both mental healthcare
services and these drugs, compared to men (8, 9). A psychotropic
drug can be defined as any drug affecting the mind, emotions
and behaviour, e.g., stimulants, antidepressants, antipsychotics,
anxiolytics, and hypnotics. Parallel to the striking increase in
psychological distress in adolescents and young adults (10, 11),
the use of psychotropic drugs among children and adolescents
has increased in many countries in the last decade (12–16). The
same trends have been observed in young adults. According
to the Norwegian Prescription Database (NorPD), the 1-year
prevalence of psychotropic drug use has increased by about 29%
in the last decade among 20–24 year-olds, to 14% in females
and 9% in males, in 2019 (17). A case study from Australia
confirmed an increasing trend in psychotropic drug prescribing
to patients aged 16–24 year with mental disorders from 2009
to 2014, with higher prescription levels in women compared to
men (18). Similarly, mental distress among Norwegian female
medical students increased from 1993 to 2015, paralleled with a
significant increase in mental health help-seeking (19).
Studies investigating psychotropic drug use among students
in relation to psychological distress are limited. A study of
21,771 students at a US university, reported increased prevalence
of past-year medical use of stimulants (from 1.9 to 4.7%),
sedatives/anxiolytics (from 2.9 to 4.3%), and hypnotics (from
2.9 to 3.2%), in the 10-year period from 2003 to 2013
(20). Further, a cross-sectional national study among nearly
11,000 French medical students reported that 12% of students
received psychiatric or psychological treatment, while 5.7% used
anxiolytics regularly, 2.8% used antidepressants, and 2.1% were
hypnoticmedication consumers (21). Despite an increasing trend
in help-seeking and use of psychotropics among young adults,
studies have reported undertreatment of mental health disorders
among students (3, 22).
Non-medical use, defined as use without a prescription
or use outside the indication of the medication (23), and
misuse or illicit use of psychotropic drugs among students is
well-documented (24–28). A meta-analysis reported an overall
rate of stimulant medication misuse among college students
of 17%, more frequent among men compared to women
(24). Motives for prescription drug misuse among students
include personal performance enhancement in academic or
sport outcomes, mental health reasons including ability to sleep
or to reduce anxiety, or manage pre-existing illnesses (29).
Additionally, the use of stimulants increases with stress (30)
and difficulties in academic achievement (31). Moreover, the
trends of increased use of prescribed psychotropic drugs among
students parallel the increased non-medical use of the same
psychotropics (20), highlighting the importance of monitoring
prevalence of psychotropic drug use among students. The correct
use of psychotropics to enhance mental health of students is
of great importance, in addition to ensuring patient safety in
this population.
Usually, young adults become fully responsible for their
medication management for the first time in life as they become
college or university students. Although the study years represent
a free and liberating period in life for many young adults, a
large portion of students experience student life as mentally
stressful and demanding and report high levels of psychological
distress (5, 11). Previous research demonstrate that psychological
distress affects students worldwide (1), recognising this as an
important public health issue. However, studies based on large,
nationwide samples including students across all faculties and
universities that allow investigation of psychological distress in
relation to the use of psychotropic drugs are still scarce. The
SHoT study is a national health and well-being survey among
Norwegian university students, and was conducted in 2010, 2014,
and 2018 (32).
The aim of this study was to study prevalence and
gender differences of psychotropic drug use among Norwegian
university students based on SHoT 2018 data, and to examine
associations with psychological distress symptom load.
MATERIALS AND METHODS
Study Sample and Setting
The SHoT study is a national student health survey for higher
education conducted every 4 years since 2010. The size and
scope of the SHoT studies has expanded over time, and this
study is based on SHoT 2018, which was a collaboration between
the Norwegian Institute of Public Health (NIPH) and the three
largest student welfare organisations in Norway. All Norwegian
fulltime students aged 18–35 years taking higher education (both
in Norway and abroad) were invited for participation (N =
162,512). Totally, 50,054 students (31% response) completed
the electronic questionnaire. SHoT 2018 includes self-reported
information on mental and physical health, quality of life, health
related behaviours, medication use, study related information,
demographics, and background factors (33). The sample of
this study includes responses from 34,437 female and 15,399
male students, excluding 218 students reporting transgender
sex, giving a final sample of 49,836 higher education students.
The response rate among females and males was 36.9 and
22.8%, respectively.
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Ethics
The SHoT 2018 study was approved by the Regional Committee
for Medical and Health Research Ethics in Western Norway
(reference number 2017/1176). Participation was voluntary,




Psychological distress symptoms were assessed using The
Hopkins Symptoms Checklist (HSCL-25). HSCL-25 is a widely
used, validated screening tool used to assess symptoms of anxiety
and depression. The scale consists of 10 items for anxiety
and 15 items for depression, each scored on a Likert scale
from 1 (not at all) to 4 (extremely) (34). The symptoms of
anxiety and depressions were assessed for the period of the
past 2 weeks. HSCL-25 has psychometric properties suitable for
detecting symptoms of anxiety and/or depression in different
population settings such as the general population (35), primary
care outpatients (36), and refugee patients with different cultural
backgrounds (37). To indicate clinically relevant psychological
distress symptom load, a cut-off at 1.75 was proposed in the
original version (34) and used in several studies (11, 36).
Additionally, a more conservative cut-off of ≥2.0 has been used
to indicate moderate to severe psychological distress symptoms
(6, 32). This study uses ≥2.0 cut-offs to describe the study
population and in the logistic regression analyses.
Psychotropic Drug Use
The use of drugs was assessed by asking if the participants had
used either of the following medicines at least once a week during
the last 4 weeks: antidepressants, anxiolytics/tranquillisers, or
hypnotics. The use of prescription analgesics, non-prescription
analgesics, anti-allergic agents, antibacterial agents, anti-
asthmatic agents, and any other medicine was also self-reported
in the SHoT 2018 questionnaire and was combined and assessed
as “any medicine” in our analysis. Response options were:
Daily; every week, but not daily; less than every week; not
used last 4 weeks. For antidepressants and “any medicine,”
the responses were analysed as: Daily use; Used last 4 weeks,
but less than daily (combining every week, but not daily
and less than every week); and Not used last 4 weeks. For
anxiolytics/tranquillisers, and hypnotics, the response were
analysed as: Used last 4 weeks; Not used last 4 weeks. Regarding
performance-enhancing drugs, the participants were asked:
During your study period, have you ever used drugs that increase
your ability to concentrate, your alertness, increase your energy,
or to calm down before exams/presentations? The possible
responses were yes or no. If answering yes, the following question
was: Which drug(s) have you used to increase your ability to
concentrate, your alertness, increase your energy, or to calm
down before exams/presentations? The questionnaire included
a list of possible drug names, for which participants could tick
one or more options: amphetamine; betablockers; donepezil;
energy drinks; caffeine tablets; methylphenidate; modafinil;
paracet (acetaminophen)/ibuprofen etc; other. The number
of study participants ticking the stimulants amphetamine,
methylphenidate, and modafinil, were summarised.
Demographic and Health Characteristics
Included variables on demographic characteristics were: sex,
age (continuous variable), relationship status (coded as single;
partner, lives alone;married, cohabitant), live alone (coded as yes
or no), foreign-born (coded as yes or no). Financial distress was
assessed by the question: “For most of the last 12 months, was
your household’s finances so that you would manage an unforeseen
bill of NOK 5,000?” (coded as yes or no). For details regarding
the financial distress variable, see Bøe et al. (38). Loneliness was
assessed by the question How often do you feel isolated from
others?, where the students were asked to indicate how often they
felt that way during the last year, on a 5-point Likert scale; never,
seldom, sometimes, often, very often. For details, see Hysing et al.
(39). Self-rated global health was assessed by asking the students
to rate their own health with the possible answers poor, fair,
good, excellent.
Statistical Analysis
Difference in self-reported psychological distress was examined
by comparing total HSCL-25 score [mean (95% confidence
interval (CI)] as well as proportions (95% CI) scoring above
the cut-offs between the groups in relation to health-related
factors, medication use, lifestyle, background information,
sociodemographic characteristics, and clinical measurements.
Generalised linear models with a log link function and identity
link function were used to calculate rate ratio (RR) and rate
difference (RD) between psychotropic drug use and self-reported
psychological distress, respectively. The models were adjusted
for age, age squared, financial distress, living alone, self-rated
health, loneliness, marital status, and foreign-born variables. We
obtained robust standard errors for the parameter estimates. RR
and RD are reported with 95 per cent confidence intervals (95%
CI). Stata v.16 was used for all data management and statistical
analysis (40).
RESULTS
Table 1 shows the demographic and health characteristics of the
university student population, including psychological distress
symptom load, gender stratified. Two thirds of students were
female, and the mean age was 23.1 and 23.5 years among women
and men, respectively. There were 7,661 foreign-born study
participants, 14.9% of the females and 16.5% of males. Half of
the study participants were single, and 19.3% lived alone. Nearly
17% of the females and 15% of the males felt lonely often or
very often. Furthermore, 58.9% of the women, and 67.7% of the
men reported financial distress. Further, 23.1% of the females
and 14.9% of the males reported “poor” or “not so good” global
health. The prevalence of moderate to severe symptom load of
anxiety and depression (HSCL-25 ≥ 2.00) was 33.6% in female
and 16.8% and male students.
Table 2 describes the self-reported psychotropic drug use.
Female students had a higher prevalence of daily antidepressants
usage (4%) thanmale students (2.3%). The female students’ usage
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TABLE 1 | Demographic and health characteristics of the student population, gender stratified.
Females n = 34,437 Males n = 15,399
n % n %
Marital status (n = 49,764)
Single 16,238 47.2 8,617 56.0
Partner, lives alone 8,258 24.0 3,582 23.3
Married, cohabitant 9,896 28.7 3,173 20.6
Living alone (n = 49,836)
No 27,992 81.3 12,210 79.3
Yes 6,445 18.7 3,189 20.7
Foreign-born/Born outside Norway (n = 49633)
No 29,175 84.7 12,797 83.1
Yes 5,128 14.9 2,533 16.5
Financial distress (n = 49,603)
No 13,960 40.5 4,922 32.0
Yes 20,291 58.9 10,430 67.7
Loneliness (n = 49,198)
Never 9,775 28.4 5,271 34.2
Seldom 10,619 30.8 4,714 30.6
Sometimes 7,866 22.8 2,954 19.2
Often 3,837 11.1 1,459 9.5
Very often 1,997 5.8 797 5.2
Self-rated global health (n = 49,751)
Poor 891 2.6 264 1.7
Fair 7,071 20.5 2,023 13.1
Good 17,138 49.8 7,359 47.8
Excellent 9,284 27.0 5,721 37.2
Psychological distress (n = 49,730)
HSCL-25* < 2.00 22,811 66.2 12,742 82.7
≥ 2.00 11,585 33.6 2,592 16.8
Age (n = 49,157) Mean SD Mean SD
Continuous 23.1 3.3 23.5 3.3
*HSCL-25, The Hopkins Symptoms Checklist.
of anxiolytics/tranquillisers and hypnotics the last 4 weeks (4.6
and 7.7%, respectively) were higher than among males (3.2 and
5.2%, respectively). The prevalence of performance-enhancing
drug use was higher among male than female students (6.5
vs. 4.8%). Totally 988 (2%) students reported to have used
amphetamine, methylphenidate, and/or modafinil during their
studies. The percent of missing data on psychotropic drug use
variables varied between 13.2 and 14.2.
Table 3 shows the adjusted associations between psychological
distress symptoms and use of psychotropics. The risk of daily use
of antidepressants was more than 2-fold increased among both
genders, with RR 2.36 and 2.09, and RD 4 and 3.4 percentage
points (pp) for males and females, respectively. Psychological
distress increased the risk of using anxiolytics/tranquillisers, with
a RR of 2.8 and 2.6 in male and female students, respectively,
and an absolute RD of 6.5 and 5.3 pp in males and females,
respectively. Furthermore, when reporting psychological distress,
the risk of daily use of hypnotics increased with approximately a
2-fold in females, and 2.2 times in males.
DISCUSSION
Main Findings
This large, nation-wide study of more than 48,000 Norwegian
students from all faculties and universities, provide information
on psychotropic drug usage among students in relation to
psychological distress, previously scarcely described in the
literature. The prevalence of psychotropic drug use was
mainly in line with results of previous studies (20, 21). Both
female and male students typically used antidepressants daily,
while anxiolytics/tranquillisers and hypnotics were used more
sporadically, which is according to clinical guidelines (41, 42).
Female students were more frequent users of antidepressants
than males (daily use in 4 vs. 2%), anxiolytics/tranquillisers (5
vs. 3% last month) and hypnotics (8 vs. 5% last month), while
the opposite was reported for stimulants (5 vs. 7%). Overall,
these results align with previous research on gender differences
in mental health and help-seeking (8, 9). In contrast, within cases
(HSCL cut-off at ≥ 2.0) patterns of psychotropic drug use were
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TABLE 2 | Prevalence of psychotropic drug use among the student population, gender stratified.
Females n = 34,437 Males n = 15,399
n % n %
Antidepressants (n = 43,017)
Daily use 1,364 4.0 361 2.3
Used last 4 weeks, but less than daily 186 0.5 105 0.7
Not used last 4 weeks 28,403 81.9 12,784 83.0
Anxiolytics/tranquillisers (n = 42,900)
Used last 4 weeks 1,590 4.6 496 3.2
Not used last 4 weeks 28,104 81.6 12,710 82.5
Hypnotics (n = 43179)
Used last 4 weeks 2,674 7.7 797 5.2
Not used last 4 weeks 27,226 79.1 12,483 81.1
Performance-enhancing drugs during studies (n = 49,563)
Yes 1,660 4.8 1,001 6.5
No 32,626 94.7 14,276 92.7
Any medicine (n = 44,102)
Daily use 7,759 22.5 1,161 7.5
Used last 4 weeks, but less than daily 2,187 6.4 701 4.6
Not used last 4 weeks 20,755 60.3 11,539 74.9
very similar in males and females, and they were about twice as
likely to take any of the psychotropic drug classes, compared to
controls (HSCL < 2.0).
Patterns of Psychotropic Drug Use in
Female and Male Students
This study describes a student population where approximately
one quarter of the respondents showed a moderate to severe
symptom load of anxiety and depression, and a previous study
has concluded that both the level and increasing prevalence of
psychological distress among Norwegian students is worrying
(11). We found that the prevalence of psychotropic drug use
varied between genders and classes of psychotropic medications.
Similar results regarding a general increase, and gender and
psychotropic drug class patterns have also been reported among
children and adolescents (12–16). In particular, an increased
use of hypnotics and antidepressants in adolescents has received
attention (12, 13, 16). Of note, the increased hypnotics usage can
largely be attributed to the increased use ofmelatonin (12, 13, 15),
which until 2020 was a prescription drug in Norway. Previous
studies have emphasised that sleep problems among students
are prevalent and increasing (33), and insomnia prevalence
is considerably higher in university students compared to the
general population (43). Therefore, continued monitoring of
hypnotics use among students is warranted, with special focus on
melatonin use and effects in this population.
This study describes a prevalence of performance-enhancing
drug use, including stimulants the last month, of 4.8 and
6.5% among females and male students, respectively. We
cannot conclude whether these drugs were illicit or misused
drugs. However, a previous study described that a substantial
proportion of the Norwegian students have tried illicit drugs, and
males more so than females (28). A meta-analysis described the
misuse of stimulant medications among students as a prevalent
and growing problem. Also, being male was associated with
misuse of stimulants, and the most common source of stimulants
access were fellow students with prescriptions (24). McCabe et al.
found that the trend of increased use of prescribed psychotropics
among students was related to the increased non-medical use
of these medications (20). Altogether, these results confirm the
need of continued monitoring prevalence of psychotropic drug
use among students and highlight the need of safeguarding the
correct use of psychotropics, in addition to ensuring patient
safety strategies in this population. For example, health services
with interprofessional healthcare teams should be accessible to
all students, being available and competent of giving advice
and counselling of proper psychotropic drug use. Educational
interventions on psychotropic drug use targeted at students,
student counsellors, and other relevant university staff could be
useful as preventive measures.
Psychotropic Drug Use in Male and Female
Students With High (HSCL ≥ 2.0) Symptom
Level
Mental health help seeking is more common in female compared
to male students (6), and previous studies of young adults
with mental health conditions have confirmed that females are
more likely to receive treatment than males (3, 18). Brijnath
et al. described an increasing trend of general practitioners’
prescription of psychotropics to young people with mental
health conditions from 2009 to 2014, and females had a higher
incident rate for prescription than males (IRR 1.15, 95% CI 1.08–
1.22) (18). In the study by Bruffaerts et al., the self-reported
receipt of mental health treatment was examined among nearly
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TABLE 3 | Adjusteda associations between psychological distress and daily psychotropic drug use, given by risk ratio (RR) and risk difference (RD) with 95 per cent
confidence interval (95% CI).
Relative and absolute differencesa
RR 95% CI RD 95% CI
Females and Malesb
Antidepressants
HSCL ≥ 2.0 2.16 (1.91–2.45) 0.036 (0.030–0.042)
Anxiolytics/tranquillisers
HSCL ≥ 2.0 2.61 (2.34–2.92) 0.055 (0.049–0.062)
Hypnotics
HSCL ≥ 2.0 2.03 (1.87–2.21) 0.068 (0.060–0.076)
Performance-enhancing drugs
HSCL ≥ 2.0 1.90 (1.72–2.09) 0.039 (0.033–0.045)
Any medicine
HSCL ≥ 2.0 1.00 (0.96–1.05) 0.003 (−0.008 to 0.014)
Females Antidepressants
HSCL ≥ 2.0 2.09 (1.82–2.40) 0.034 (0.028–0.040)
Anxiolytics/tranquillisers
HSCL ≥ 2.0 2.60 (2.28–2.96) 0.053 (0.046–0.060)
Hypnotics
HSCL ≥ 2.0 1.99 (1.82–2.19) 0.066 (0.057–0.075)
Performance-enhancing drugs
HSCL ≥ 2.0 1.92 (1.70–2.17) 0.034 (0.028–0.041)
Any medicine
HSCL ≥ 2.0 1.00 (0.95–1.05) 0.001 (−0.012 to 0.013)
Males Antidepressants
HSCL ≥ 2.0 2.36 (1.78–3.13) 0.040 (0.028–0.053)
Anxiolytics/tranquillisers
HSCL ≥ 2.0 2.81 (2.23–3.55) 0.065 (0.050–0.080)
Hypnotics
HSCL ≥ 2.0 2.21 (1.84–2.66) 0.076 (0.057–0.094)
Performance-enhancing drugs
HSCL ≥ 2.0 1.87 (1.58–2.21) 0.056 (0.039–0.073)
Any medicine
HSCL ≥ 2.0 1.06 (0.90–1.24) 0.006 (−0.013 to 0.025)
a HSCL < 2.0 was used as reference in all analyses, with RR = 1 and RD = 0. Adjusted for age, age squared, financial distress, living alone, self-rated health, loneliness, marital status,
and foreign-born.
b Also adjusted for sex.
14,000 first year students from 19 colleges in eight countries
world-wide. They reported on sociodemographic predictors of
treatment, where being female was an independent predictor of
both lifetime and 12-month treatment (3). In our study, however,
the use of psychotropic drugs among female and male students
with psychological distress was more or less identical across all
psychotropic drug classes.
Evidently, help-seeking involves opportunities for diagnosis
and treatment, and implies positive association to medication
usage. However, several factors are known to affect the use
of mental healthcare among young adults, e.g., type and
severity of mental health problem, stigma, mental health
literacy, socioeconomic position, healthcare organisation
and infrastructure (8, 44), that would subsequently influence
possibilities for detection of treatment needs. Furthermore,
help-seeking among students is generally low, varies
between university and college campuses, and across student
characteristics (6, 45, 46). Accordingly, a high unmet need
for treatment of mental disorders among students has been
recognised (3, 22). Further research regarding psychotropic drug
use among students with mental health problems is warranted,
and should involve longitudinal studies, and examine gender
differences of causal and treatment factors, as well as medication
safety issues in this population. Furthermore, systematic
strategies to increase detection of need for mental health
treatment among university students is of great importance, and
might need several interventions at different levels, including
an interdisciplinary approach. Generally, health authorities and
Frontiers in Psychiatry | www.frontiersin.org 6 September 2021 | Volume 12 | Article 717955
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universities need to focus on student mental health, to reduce
psychological distress among students, and encourage students
to seek help when needed.
Strengths and Limitations
The main strength of this study is the large, national sample of
university students.
Limitations include the modest response rate (31%) and
the potential selection bias regarding the prevalence measures
and associations (32). Furthermore, self-reported anxiety and
depression symptoms were assessed using the HSCL-25 with
a conventional cut-off at ≥2.0. Although commonly used, and
often the only feasible method in large scale studies, self-
reported symptom levels do not compare directly to diagnostic
categories of these conditions. Similarly, the self-reported use of
medication has obvious limitations compared to register data,
and the SHoT 2018 survey did not include information on
whether the psychotropics were obtained through a prescription.
The self-reported psychotropic drug usage was reported as
daily or monthly prevalence, and are thereby not directly
comparable to past-year prevalence commonly used in other
pharmacoepidemiologic studies.
CONCLUSION
Our study suggests similar prevalence and gender patterns of
intake of the most common psychotropic drug classes among
Norwegian students, compared to European and US studies (20,
21). The vast majority of antidepressant users took their drugs
daily, according to the prescription guidelines (41). In contrast,
anxiolytics and sedatives were taken more infrequently, which is
also recommended. Althoughmental health help seeking is much
more common in female compared to male students (6, 19), the
patterns of drug use in female and male students were more or
less identical across all psychotropic drug classes in our study.
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